Fujue Wang

机构：Sichuan University, West China Hospital of Sichuan University, First Affiliated Hospital of University of South China, State Key Laboratory of Biotherapy, University of South China · ORCID：0000-0002-5360-1235

发表论文 38 篇 · 总被引 363 次 · h-index 9

代表论文

• Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling (2021 · Cellular Signalling · 被引 78)
• A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia (2022 · Frontiers in Oncology · 被引 36)
• Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway (2023 · Oncology Reports · 被引 29)
• Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis (2021 · BMC Cancer · 被引 14)
• Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS) (2024 · Frontiers in Pharmacology · 被引 13)
• CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma (2023 · Journal of Orthopaedic Surgery and Research · 被引 9)